Development of mesalazine pellets coated with methacrylic-derived polymer

• Hoofdauteurs: Simone Cristina Déo (Auteur), Itamar Francisco Andreazza (Auteur), João Carlos Possamai (Auteur)
• Formaat: Boek
• Gepubliceerd in: Universidade de São Paulo, 2011-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Mesalazine (5-ASA) is the standard drug for the treatment of inflammatory bowel disease (IBD) due to its local effect on intestinal and colonic mucosa. The effective and safe treatment of this disease requires more efficient delivery of the active substance to its site of action. The focus of this s...